2 ms·
Why is this surprising? Big Pharma is not good at innovation so they buy and partner with companies that have done the hard R&D and they focus on commercializat
by rdlecler1 3y ago
Why is this surprising? Big Pharma is not good at innovation so they buy and partner with companies that have done the hard R&D and they focus on commercialization, distribution and manufacturing. It doesn’t mean that pharma R&D is not being done, it’s just that pharma companies are not paying for R&D they are paying up for commercializable assets.